A new weight loss drug has been scientifically reviewed for cardiovascular risk, and found to not increase such risk in patients who are above their normal weight. Each participant in the study was diagnosed with either more than one risk factor for heart disease, or already had cardiovascular disease with atherosclerotic aspects. The study ran […]
No comments:
Post a Comment